Effect of Esketamine on 95% Induction Dose of Remimazolam
Clinical trial NCT06303037 · COMPLETED
Trial details
- NCT number
- NCT06303037
- Sponsor
- Second Affiliated Hospital of Wenzhou Medical University
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-01
- Primary completion
- 2024-08-29
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.